Phase III trial tests TTFields plus standard therapy for stage 4 NSCLC after platinum failure
Can adding electric fields to standard treatment help people with advanced lung cancer?
A prospective, randomized phase III trial in 291 patients with stage 4 NSCLC after platinum progression compared TTFields plus standard ther…
Doctors are testing if adding a wearable electric field device to standard drugs helps people with advanced lung cancer live longer after ch…
Low sADC Predicts Poor Outcomes in Cervical Cancer with PD-1 Inhibitors
Can imaging predict how well cervical cancer patients respond to treatment?
In a study of 167 cervical cancer patients, lower substantial ADC (sADC) correlated with worse PFS (HR=1.81, P=0.005) and OS (HR=2.40, P=0.0…
Low water movement in cervical cancer tumors on scans predicts worse survival when patients take immunotherapy, helping doctors choose bette…
Phase 2 Study: L-SABR Plus Standard Therapy in Metastatic NSCLC Patients
Could Targeted Radiation Therapy Offer Hope for Lung Cancer Patients?
This Phase 2 trial evaluates the addition of liver stereotactic ablative radiotherapy (L-SABR) to standard drug therapy in metastatic NSCLC.
A new trial tests if adding targeted liver radiation to standard drugs helps metastatic lung cancer patients live longer without disease pro…